MediCann

What MediCann does

MediCann is a privately held medical cannabis consultation and telemedicine company founded in 2004 by Dr. Jean Talleyrand, who was among the first physicians to recommend cannabis in California following Proposition 215. The company provides physician evaluations and written recommendations that enable patients in California, Texas, Oklahoma, and Georgia to legally access medical cannabis for qualifying conditions such as chronic pain, anxiety, cancer, migraines, PTSD, and insomnia. Its core service is a 15-30 minute physician consultation delivered in person or via telemedicine through third-party platforms (Acuity Scheduling, VerifyMC, GetHeally), supported by a 24/7 patient verification system used by dispensaries and authorities, condition-specific patient education content, and an annual membership program that bundles the consultation, an ID card, and a patient exchange program.

MediCann operates a hub-and-affiliate model in which a network of licensed affiliate physicians across 20+ cities provides evaluations under the MediCann brand, supplemented by an Affiliate Provider Program that licenses the brand, training, and verification infrastructure to independent physicians. In 2015 the company restructured from a direct patient-care practice into a "medical cannabis intermediary and media group," extending into content, education, and research. Its research arm, The Dosing Project, is run in partnership with the non-profit Clinical Endocannabinoid System Consortium (CESC) and collects patient-reported dosing data to establish evidence-based guidelines for pain and insomnia. Additional partnerships include Flore Dispensary in San Francisco for product access and Holistic Caring for nurse-led patient education.

Revenue is generated through three streams: per-consultation fees for physician evaluations (professional services), an annual membership subscription bundling consultation, ID, education, and exchange access, and licensing royalties from the Affiliate Provider Program. MediCann has no disclosed funding, is founder-controlled by Dr. Talleyrand, and operates with a small core team (11-50 employees) supplemented by its affiliate network.

Name

MediCann

Legal name

MediCann

Website

https://medicann.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

MediCann is a privately held medical cannabis telemedicine and consultation company, founded in 2004, that provides physician evaluations and state cannabis recommendations to patients across California, Texas, Oklahoma, and Georgia via direct clinics and an affiliate provider network, supplemented by research, education, and membership programs.

Ownership category

akta.pro rank

Product category

Medical Cannabis Consultation Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)

Keywords

• Medical cannabis consultations
• Telehealth cannabis evaluations
• Medical marijuana cards
• Cannabis patient recommendations
• Telemedicine physician services

Headquarters

HQ city

Oakland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Physician Consultations: Medical cannabis evaluations and consultations conducted via telemedicine, where patients pay for physician consultations and recommendations.
2. Membership Program: Annual membership program offering physician consultation, membership ID, monthly newsletter, cannabis education, patient exchange program access, and resources.
3. Affiliate Provider Licensing: Exclusive license to use the MediCann brand in geographic regions, provider guides, cannabis education courses, and verification/card services for affiliated physicians.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

MediCann provides medical cannabis evaluation and recommendation services through state-licensed physicians, offering telemedicine and in-person consultations for patients with qualifying conditions such as chronic pain, anxiety, cancer, migraines, and PTSD. The company facilitates state medical cannabis ID card issuance across California, Texas, Oklahoma, and Georgia, and operates a physician affiliate licensing program that extends its brand and verification services to additional providers.

Product overview

MediCann is a medical cannabis consultation and patient services company founded in 2004 by Dr. Jean Talleyrand. The company operates a multi-service platform consisting of physician consultation services and medical cannabis recommendations as the core offerings, supported by telemedicine appointments, patient education resources, and membership programs. The product portfolio includes: the core Physician Consultation and Card/Recommendation Services for evaluating patients and providing legal access to medical cannabis; The Dosing Project research initiative conducted in partnership with CESC for evidence-based dosing research; the Patient Exchange Program enabling patient-to-patient cannabis sharing with proceeds supporting research; the Affiliate Provider Program licensing physicians to offer cannabis evaluations; and partnership integrations with Holistic Caring nursing services and Flore Dispensary for expanded patient access. The company operates across California, Georgia, Oklahoma, and Texas, serving patients seeking medical cannabis evaluations and recommendations through in-person and telemedicine consultations.

Differentiator

Problem solved

Functional benefit

Brands

• The Dosing Project: A collaborative clinical research initiative with CESC to establish dosing guidelines for medical cannabis based on patient study data.

Products and services

• Physician Consultation Services In-person and remote medical cannabis evaluations and recommendations provided by state-licensed physicians for patients with qualifying medical conditions, including dosing and product-type guidance.
• Telemedicine Appointments

Quantifiable outcome

• Nearly 500,000 cannabis evaluations and recommendations performed
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Clinical Endocannabinoid System Consortium (CESC)coreStrategic or Co-development PartnerMediCann partners with CESC, a non-profit organization, to advance the science and medicine behind medical cannabis. Together they conduct The Dosing Project, a clinical research initiative exploring cannabis dosing for pain and insomnia management. This partnership provides credibility through scientific research and clinical validation.
• Flore DispensaryminorChannel Partner/ Reseller/ DistributorMediCann collaborates with Flore Dispensary in San Francisco's Castro District. The partnership allows MediCann members to access cannabis products through the dispensary, with free products available for pickup. The collaboration focuses on patient care and embracing science and history in the cannabis industry.
• Holistic CaringminorChannel Partner/ Reseller/ DistributorHolistic Caring is a Medical Cannabis Nursing Organization that provides Skype, phone, or at-home appointments with nurses specializing in medical cannabis. They assist patients in understanding how to best use cannabis for treating ailments and improving health and quality of life.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• NuggMD: NuggMD is one of the largest U.S. cannabis telemedicine platforms, offering online medical cannabis evaluations and recommendations across multiple states — a direct competitor to MediCann's core service in states of overlap.
• Leafwell: Leafwell operates a national telehealth platform for medical cannabis certifications, serving patients in 30+ U.S. states with a digital-first experience — directly comparable to MediCann's telemedicine evaluation model.
• PrestoDoctor: PrestoDoctor provides online medical cannabis recommendations and ID cards via licensed physicians via telehealth, serving multiple U.S. states — overlapping directly with MediCann's evaluation and recommendation offering.
• VeriHeal: VeriHeal connects patients to licensed cannabis doctors for medical marijuana certifications across multiple states, operating a telehealth plus clinic hybrid similar in concept to MediCann's service.
• Green Health Docs: Green Health Docs is a multi-state medical cannabis certification provider offering in-person and online evaluations with a physician network — directly comparable in service line and geographic expansion model to MediCann.
• Canna Care Docs: Canna Care Docs operates a multi-state network of clinics and telemedicine services for medical cannabis certifications, closely aligned with MediCann's physician-evaluation-and-recommendation model.
• Elevate Holistics: Elevate Holistics provides online medical cannabis recommendations and cards across multiple U.S. states via a digital-first telehealth flow — a direct competitor to MediCann's evaluation service.

Emerging players

• Holistic Caring: Holistic Caring is a medical cannabis nursing organization that MediCann already partners with; it offers Skype, phone, and at-home nurse consultations on cannabis use — an adjacent clinical service model with overlap in patient education and condition management.

Broad incumbents

• Eaze: Eaze is a large California-based cannabis delivery and marketplace platform; it sits adjacent to MediCann because it touches the patient–cannabis access pathway but does not specialize in physician evaluations the way MediCann does.
• Dutchie: Dutchie is a leading cannabis retail technology and marketplace platform serving dispensaries nationwide; it competes in the broader cannabis patient access ecosystem and represents an incumbent that could expand into clinical services adjacent to MediCann's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/MediCann

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MediCann